539561 — Remedium Lifecare Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual income statement for Remedium Lifecare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final
Revenue
Total Revenue	900	5,048	5,098	40,417
Cost of Revenue
Gross Profit	22.9	63.2	160	403
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	894	5,032	5,025	40,085
Operating Profit	6.53	16.3	73.2	332
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	6.53	15.3	74	505
Provision for Income Taxes
Net Income After Taxes	4.8	10.8	54.3	327
Net Income Before Extraordinary Items
Net Income	4.8	10.8	54.3	327
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4.8	10.8	54.3	327
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.008	0.019	0.094	0.567